Ahepa Hospital
Thessaloniki 54636
0 studies enrolling now · 6 studies all time
What they study most
Acute Respiratory Failure, Diabetes Mellitus, Type 2, HIV Infections, Type 2 Diabetes Mellitus
Studies at this site
- Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
- A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk — Completed
- A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes — Completed
- A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes — Completed
- Third International Study on Mechanical Ventilation — Completed
- Expanded Access Program for Maraviroc At Multiple Centers — Completed